Join some of the most respected 340B veterans for an interactive panel discussion on the latest updates impacting the 340B program. Marsha Simon and William von Oehsen helped to draft the original 340B legislation 30 years ago, and they’ll share their perspective on the evolution of the program and what’s next. You will also hear from other 340B experts, including Ted Slafsky of 340B Report and Cathy White of Cone Health.
This session will provide insights into:
- How the 340B program has evolved over the last 30 years
- What the Supreme Court’s decision on Medicare Part B cuts means for 340B hospitals
- The latest developments on Capitol Hill and the Administration
- Growing momentum at the state and federal levels for 340B protections
- Ways you can take action to protect 340B
This influential event is the go-to place to get inspired by the industry’s best and brightest and gain valuable insights into the ever-changing 340B program.
340B Sales and Account Management
Jeff Spencer is an experienced leader and consultant in the healthcare industry, with special expertise in relationship management, 340B drug programs and health system pharmacy strategies. Throughout his career, Jeff has helped a diverse range of clients successfully develop and implement 340B programs that improve cost-effectiveness, operational efficiency and patient health outcomes.
Marsha Simon, PhD
MJ Simon & Company
Dr. Simon is an expert in legislative strategy, nonprofit management, and public policy research, with over 20 years of experience, including nearly a decade working for the United States Senate. She served as senior committee staffer to Senators Edward M. Kennedy, Tom Harkin, and Robert C. Byrd, advising them on public health and welfare policy, as well as on the budget and appropriations processes.
Publisher and CEO
Ted Slafsky is one of the nation’s leading experts on healthcare policy, pharmaceutical pricing, the hospital industry and healthcare access. Based in Washington, DC, he is Founder and Principal of Wexford Solutions LLC where he consults with businesses and non-profits looking to strengthen their position in the marketplace and improve healthcare outcomes. Mr. Slafsky is also the Publisher and CEO of 340B Report.
William H. von Oehsen lll
William von Oehsen has more than 30 years experience on pharmaceutical pricing and reimbursement matters, including the 340B drug discount program, the Medicaid drug rebate program, Medicare Part D, Robinson-Patman, and state Medicaid and pharmacy laws. He helped establish and serves as outside counsel to 340B Health, an advocacy organization of over 1,400 public and private non-profit hospitals participating in the 340B program.
340B Pharmacy Financial Analyst
Cathy White is a seasoned analyst who believes the vital piece to 340B compliance is self-auditing. She is a healthcare professional with over 25 years of experience in multiple segments of the pharmaceutical industry, including community retail, field auditing on behalf of a pharmacy benefits manager, and currently a 340B analyst for a large not-for profit health care network. In her current role, she is responsible for auditing several mixed-use acute hospitals, wholly-owned retail pharmacies, and a complex contract pharmacy program.